94 related articles for article (PubMed ID: 15686745)
1. Experimental limb transplantation, part III: induction of tolerance in the rigorous strain combination of Brown Norway donor to Lewis recipient.
Kanatani T; Wright B; Lanzetta M; Molitor M; McCaughan GW; Bishop GA
Transplant Proc; 2004 Dec; 36(10):3276-82. PubMed ID: 15686745
[TBL] [Abstract][Full Text] [Related]
2. Donor leukocytes combine with immunosuppressive drug therapy to prolong limb allograft survival.
Kanatani T; Lanzetta M; Owen E; Matsumoto T; Fujioka H; Kurosaka M; McCaughan GW; Bishop GA
Transplant Proc; 2005 Jun; 37(5):2382-4. PubMed ID: 15964421
[TBL] [Abstract][Full Text] [Related]
3. Experimental limb transplantation, part I: identification of an effective tapered triple combination immunosuppressive regime.
Ayrout C; Lanzetta M; Chunasuwankul R; Gal A; Owen ER
Transplant Proc; 2004 Apr; 36(3):669-74. PubMed ID: 15110627
[TBL] [Abstract][Full Text] [Related]
4. Donor leukocytes combined with delayed immunosupressive drug therapy prolong limb allograft survival.
Matsumoto T; Kanatani T; Lanzetta M; Fujioka H; Kurosaka M; McCaughan GW; Bishop GA
Transplant Proc; 2005 Dec; 37(10):4630-3. PubMed ID: 16387186
[TBL] [Abstract][Full Text] [Related]
5. Prolonged survival of rat hindlimb allografts following short-course FK506 and mycophenolate mofetil combination therapy.
Song YX; Muramatsu K; Kurokawa Y; Taguchi T
Microsurgery; 2005; 25(4):353-9. PubMed ID: 15880483
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin, mycophenolate mofetil, methylprednisolone, and cytotoxic T-lymphocyte-associated antigen 4 immunoglobulin-based conditioning regimen to induce partial tolerance to hind limb allografts without cytoreductive conditioning.
Pan H; Wang L; Zhang X; Zhang G; Mai H; Han Y; Guo S
Transplant Proc; 2008 Jun; 40(5):1714-21. PubMed ID: 18589179
[TBL] [Abstract][Full Text] [Related]
7. Neuroregeneration in composite tissue allografts: effect of low-dose FK506 and mycophenolate mofetil immunotherapy.
Cottrell BL; Perez-Abadia G; Onifer SM; Magnuson DS; Burke DA; Grossi FV; Francois CG; Barker JH; Maldonado C
Plast Reconstr Surg; 2006 Sep; 118(3):615-23; discussion 624-5. PubMed ID: 16932168
[TBL] [Abstract][Full Text] [Related]
8. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
Siemionow MZ; Izycki DM; Zielinski M
Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
[TBL] [Abstract][Full Text] [Related]
9. Experimental limb transplantation, part II: excellent return of function and indefinite survival after withdrawal of immunosuppression.
Lanzetta M; Ayrout C; Gal A; Dereli Z; Wright B; Lauer C; Owen ER
Transplant Proc; 2004 Apr; 36(3):675-9. PubMed ID: 15110628
[TBL] [Abstract][Full Text] [Related]
10. The effect of full dose composite tissue allotransplantation immunosuppression on allograft motor nerve regeneration in a rat sciatic nerve model.
Kim JP; Hundepool CA; Friedrich PF; Moran SL; Bishop AT; Shin AY
Microsurgery; 2018 Jan; 38(1):66-75. PubMed ID: 28792625
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of glucocorticoid-free immunosuppressive regimen in allogenic islet transplantation.
Du CY; Xu EK
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):43-7. PubMed ID: 16481281
[TBL] [Abstract][Full Text] [Related]
12. Composite tissue allotransplantation in chimeric hosts part II. A clinically relevant protocol to induce tolerance in a rat model.
Prabhune KA; Gorantla VS; Perez-Abadia G; Francois CG; Vossen M; Laurentin-Perez LA; Breidenbach WC; Wang GG; Anderson GL; Pidwell DJ; Barker JH; Maldonado C
Transplantation; 2003 Dec; 76(11):1548-55. PubMed ID: 14702522
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
15. Combined immunosuppression of mycophenolate mofetil and FK506 for myoblast transplantation in mdx mice.
Camirand G; Caron NJ; Asselin I; Tremblay JP
Transplantation; 2001 Jul; 72(1):38-44. PubMed ID: 11468532
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil and FK506: two novel immunosuppressants in murine corneal transplantation.
Reis A; Reinhard T; Sundmacher R; Braunstein S; Godehardt E
Transplant Proc; 1998 Dec; 30(8):4344-7. PubMed ID: 9865380
[No Abstract] [Full Text] [Related]
17. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival of an extremity composite tissue allograft with FK506-mycophenolate mofetil therapy.
Jones JW; Ustüner ET; Zdichavsky M; Edelstein J; Ren X; Maldonado C; Ray M; Jevans AW; Breidenbach WC; Gruber SA; Barker JH
Surgery; 1999 Aug; 126(2):384-8. PubMed ID: 10455910
[TBL] [Abstract][Full Text] [Related]
19. Long-term viability of articular cartilage after microsurgical whole-joint transplantation and immunosuppression with rapamycin, mycophenolate mofetil, and tacrolimus.
Vögelin E; Jones NF; Rao UN
J Hand Surg Am; 2002 Mar; 27(2):307-15. PubMed ID: 11901390
[TBL] [Abstract][Full Text] [Related]
20. The effect of bone marrow transplantation on survival of allogeneic pancreatic islets with short-term tacrolimus conditioning in rats.
Girman P; Kríz J; Dovolilová E; Cíhalová E; Saudek F
Ann Transplant; 2001; 6(2):43-5. PubMed ID: 11803619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
